Histological Study of the Effects of a 2910 nm Fiber Laser Technology

Launched by FA CORPORATION · Mar 12, 2024

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Healthy male and female adults between 18-75 years of age.
• • Subjects who can read, understand, and sign the Informed Consent Form.
• • Subjects willing and able to comply with all study requirements.
• • Fitzpatrick skin types I-IV.
• • Subjects who have pre-scheduled a body or facial contouring procedure.
• Exclusion Criteria:
• • Subjects with active localized or systemic infections
• • Immunocompromised subjects
• • Subjects with coagulation disorder
• • History of radiation therapy to treatment area
• • Subject with a history of lidocaine or ester-based local anesthetics
• • Pacemaker or internal defibrillator
• • Superficial or metal implants in the area
• • Current or history of skin cancer, as well as any other type of cancer, or pre-malignant moles.
• • Severe concurrent conditions, such as cardiac disorders
• • Pregnancy and nursing
• • Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications.
• • Diseases which may be stimulated by light at the wavelengths used, such as history of Systemic Lupus Erythematosus, Porphyria, and Epilepsy.
• • Patients with a history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treatment area, may be treated only following a prophylactic regime.
• • Any active condition in the treatment area, such as sores, psoriasis eczema, and rash.
• • History of skin disorders, keloids, abnormal wound healing, as well as very dry and fragile skin.
• • History of bleeding coagulopathies or use of anticoagulants.
• • Use of medication and herbs known to induce photosensitivity to light exposure at the wavelengths used, such as Isotretinoin (Accutane) within the last 6 months, tetracyclines, or St. John's Wort within the last two weeks.
• • Any surgical procedure in the treatment area within the last 3 months or before complete healing.
• • Tattoo or permanent makeup in the treatment area.
• • Excessively tanned skin from sun, tanning beds or tanning creams within last the two weeks.
• • As per the practitioner's discretion, refrain from treating any condition which might make it unsafe for the patient